A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Evaluation of PLN-74809 on Type 1 Collagen Deposition Using 68Ga-CBP8 PET/MRI Imaging in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Latest Information Update: 20 Feb 2025
At a glance
- Drugs Bexotegrast (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- Acronyms PLN-74809
- Sponsors Pliant Therapeutics
Most Recent Events
- 10 Sep 2024 According to a Pliant Therapeutics media release, data from this study was presented at the European Respiratory Society (ERS) International Congress 2024 taking place in Vienna, Austria September 7-11, 2024.
- 14 May 2024 According to a Pliant Therapeutics media release, the company announced topline data from a 12-week data from this trial.
- 14 May 2024 Results published in the Pliant Therapeutics Media Release